- Home
- KROS vs LEGH Comparison
KROS vs LEGH Comparison
Compare KROS & LEGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KROS | LEGH |
|---|---|---|
| Founded | 2015 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 655.9M | 495.0M |
| IPO Year | 2020 | 2018 |
Fundamental Metrics
Financial Performance| Metric | KROS | LEGH |
|---|---|---|
| Price | $21.02 | $20.05 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 3 |
| Target Price | $22.20 | ★ $25.00 |
| AVG Volume (30 Days) | ★ 1.0M | 130.5K |
| Earning Date | 11-05-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 1.57 | ★ 1.95 |
| Revenue | ★ $246,718,000.00 | $180,497,000.00 |
| Revenue This Year | $6,876.34 | N/A |
| Revenue Next Year | N/A | $6.07 |
| P/E Ratio | $12.87 | ★ $10.18 |
| Revenue Growth | ★ 37798.31 | 10.25 |
| 52 Week Low | $9.12 | $18.84 |
| 52 Week High | $22.55 | $29.45 |
Technical Indicators
Market Signals| Indicator | KROS | LEGH |
|---|---|---|
| Relative Strength Index (RSI) | 64.05 | 46.04 |
| Support Level | $19.76 | $19.62 |
| Resistance Level | $21.75 | $20.94 |
| Average True Range (ATR) | 1.08 | 0.65 |
| MACD | -0.11 | 0.12 |
| Stochastic Oscillator | 75.44 | 49.06 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About LEGH Legacy Housing Corporation (TX)
Legacy Housing Corp builds, sell, and finance manufactured homes and tiny houses that are distributed through a network of independent retailers and company-owned stores and also sold directly to manufactured home communities. The company also provides financing options to its customers to facilitate the sale of homes.